Lactation specialist warns against use of Reglan
Melissa Kotlen Nagin is not a fan of the prescription drug Reglan, especially to stimulate milk production in breast feeding mothers. Nagan, a mother of three, is an International Board Certified Lactation Consultant and Registered Lactation Consultant who maintains an active private practice, teaches prenatal breastfeeding classes in New York City, and lectures on lactation topics at The Mount Sinai Hospital in New York City. She has assisted hundreds of women on breastfeeding issues in the past eight years. Lately, she has fielded numerous questions from her clients about how to increase milk supply. She says, “For the majority, aside from increasing stimulation, we talk about going the herbal route; for a smattering, we chat about Domperidone. For NONE do I discuss Reglan.”
Last December, Sen. John McCain identified Irritable Bowel Syndrome (IBS) as an illness unworthy of receiving funds for research, citing an earmarked $665,000 for the Cedar Sinai Medical Center in Los Angeles, California, for equipment and supplies to research the debilitating condition. This triggered the Gastroparesis Patient Association for Cures and Treatment (G-PACT), an organization that raises awareness of gastric mobility disorders, to write a petition to present to Sen. McCain on March 8, 2010. The petition stresses that the money is used to assist in the “funding innovating GI motility research by Cedars Sinai to study the use of various antibiotics to enhance GI mobility and prevent severe bacterial overgrowth in various GI motility disease,” usage deemed worthy by many who suffer from GI disorders.